These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bisphophonates in CKD patients with low bone mineral density. Liu WC, Yen JF, Lang CL, Yan MT, Lu KC. ScientificWorldJournal; 2013; 2013():837573. PubMed ID: 24501586 [Abstract] [Full Text] [Related]
6. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats. Meng Y, Zhang H, Li Y, Li Q, Zuo L. Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307 [Abstract] [Full Text] [Related]
8. [Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)]. Cejka D, Wakolbinger-Habel R, Zitt E, Fahrleitner-Pammer A, Amrein K, Dimai HP, Muschitz C. Wien Med Wochenschr; 2023 Oct; 173(13-14):299-318. PubMed ID: 36542221 [Abstract] [Full Text] [Related]
9. Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study. Ray S, Beatrice AM, Ghosh A, Pramanik S, Bhattacharjee R, Ghosh S, Raychaudhury A, Mukhopadhyay S, Chowdhury S. Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S931-S937. PubMed ID: 28728874 [Abstract] [Full Text] [Related]
10. Adynamic bone disease: from bone to vessels in chronic kidney disease. Bover J, Ureña P, Brandenburg V, Goldsmith D, Ruiz C, DaSilva I, Bosch RJ. Semin Nephrol; 2014 Nov; 34(6):626-40. PubMed ID: 25498381 [Abstract] [Full Text] [Related]
16. Trabecular reorganization in consecutive iliac crest biopsies when switching from bisphosphonate to strontium ranelate treatment. Jobke B, Burghardt AJ, Muche B, Hahn M, Semler J, Amling M, Majumdar S, Busse B. PLoS One; 2011 Nov; 6(8):e23638. PubMed ID: 21858188 [Abstract] [Full Text] [Related]
17. Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment. Haarhaus M, Evenepoel P, European Renal Osteodystrophy (EUROD) workgroup, Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA). Kidney Int; 2021 Sep; 100(3):546-558. PubMed ID: 34102219 [Abstract] [Full Text] [Related]
18. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study. Haarhaus M, Monier-Faugere MC, Magnusson P, Malluche HH. Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703 [Abstract] [Full Text] [Related]
19. Treatment of metabolic bone disease in patients with chronic renal disease: a perspective for rheumatologists. Miller PD. Curr Rheumatol Rep; 2005 Mar; 7(1):53-60. PubMed ID: 15760581 [Abstract] [Full Text] [Related]
20. Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH. Coen G, Ballanti P, Bonucci E, Calabria S, Costantini S, Ferrannini M, Giustini M, Giordano R, Nicolai G, Manni M, Sardella D, Taggi F. Nephron; 2002 May; 91(1):103-11. PubMed ID: 12021526 [Abstract] [Full Text] [Related] Page: [Next] [New Search]